CYCLOPENTA [D]-PYRIMIDINE ALS AKT-PROTEINKINASEHEMMER

The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for...

Full description

Saved in:
Bibliographic Details
Main Authors CHABOT, CHRISTINE, BLAKE, JAMES F, SCHLACHTER, STEPHEN.T, BANKA, ANNA.L, SPENCER, KEITH LEE, LIANG, JUN, XIAO, DENGMING, BENCSIK, JOSEF R, XU, RUI, KALLAN, NICHOLAS C, MITCHELL, IAN S, WALLACE, ELI. M, SAFINA, BRIAN, LI, JUN
Format Patent
LanguageGerman
Published 15.09.2011
Online AccessGet full text

Cover

More Information
Summary:The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Bibliography:Application Number: AT20070799329T